ArticleDrug delivery and translational research2022

The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles.

Kanawat Wiwatchaitawee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.